title: Chemotherapy parity laws: a remedy for high drug costs?
authors.affiliation: Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Bo
authors.initials: B
authors.lastname: Wang
authors.affiliation: Department of Medical Ethics and Health Policy at the Perelman School of Medicine, University of Pennsylvania, Philadelphia.
authors.forename: Steven
authors.initials: S
authors.lastname: Joffe
authors.affiliation: Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
mesh_terms: D061605:Administration, Intravenous; D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000191:economics*; D003361:Cost Allocation; D017047:Cost Sharing; D016527:Drug Costs; D006801:Humans
chemical_list: D000970:Antineoplastic Agents